quinazolines has been researched along with C gattii Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baró-Tomás, T; Jiménez-Cabello, T; Morera-López, Y; Torres-Rodríguez, JM | 1 |
| Hariri, AR; Larsh, HW | 1 |
2 other study(ies) available for quinazolines and C gattii Infection
| Article | Year |
|---|---|
Cryptococcus gattii: in vitro susceptibility to the new antifungal albaconazole versus fluconazole and voriconazole.
Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Soil Microbiology; Triazoles; Voriconazole | 2005 |
In vitro and in vivo activity of 2,4-diamino-6-(2-(3,4-dichlorophenyl)acetamido) quinazoline against Cryptococcus neoformans.
Topics: Antifungal Agents; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Fungal Proteins; Quinazolines; RNA | 1976 |